Two-year outcomes of clinical N2-3 esophageal squamous cell carcinoma after neoadjuvant chemotherapy and immunotherapy from the phase 2 NICE study
Yang Yang, Jun Liu, Zhichao Liu, Li Zhu, Hezhong Chen, Bentong Yu, Renquan Zhang, Jinchen Shao, Ming Zhang, Chun Guang Li, Zhigang Li
Topics & Concepts
MedicineInternal medicineInterquartile rangeChemotherapyHazard ratioEsophagectomyEsophageal cancerOncologyRegimenNeoadjuvant therapyCarboplatinGastroenterologyPhases of clinical researchSurgeryConfidence intervalCancerBreast cancerCisplatinEsophageal Cancer Research and TreatmentCancer Immunotherapy and BiomarkersColorectal and Anal Carcinomas